MARKET

HQL

HQL

abrdn Life Sciences Investors
NYSE
15.36
+0.06
+0.39%
Opening 13:21 07/22 EDT
OPEN
15.44
PREV CLOSE
15.30
HIGH
15.52
LOW
15.29
VOLUME
54.98K
TURNOVER
0
52 WEEK HIGH
15.63
52 WEEK LOW
11.03
TOTAL ASSET
466.81M
YTD YIELD
16.64%
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at HQL last week (0715-0719)?
Weekly Report · 8h ago
HQH: Discount Remains Attractive With A Now Higher Distribution Rate
Abrdn Healthcare Investors Fund focuses on the more cyclical biotech space, with over half of its portfolio allocated there. The fund's managed distribution policy was increased significantly since our prior update. The abrdn healthcare investors fund continues to trade at an attractive discount. Discount Narrows With Distribution Increase But Remains Appealing.
Seeking Alpha · 4d ago
Weekly Report: what happened at HQL last week (0708-0712)?
Weekly Report · 07/15 09:21
Weekly Report: what happened at HQL last week (0701-0705)?
Weekly Report · 07/08 09:22
Weekly Report: what happened at HQL last week (0624-0628)?
Weekly Report · 07/01 09:22
Weekly Report: what happened at HQL last week (0617-0621)?
Weekly Report · 06/24 09:23
Weekly Report: what happened at HQL last week (0610-0614)?
Weekly Report · 06/17 09:22
Weekly Report: what happened at HQL last week (0603-0607)?
Weekly Report · 06/10 09:22
More
Profile
Fund Name
abrdn Life Sciences Investors
Inception Date
1992-05-08
Benchmark
NASDAQ Biotechnology TR USD
Advisor Company
Tekla Capital Management LLC
Custodian
State Street Bank and Trust Co
Manager
Jason Akus, Daniel Omstead